These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19526393)

  • 1. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
    Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
    Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
    Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
    Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroxyl antioxidant TPPA-TEMPO increases the efficacy of antitumor therapy on the model of transplantable mouse tumor.
    Kirilyuk IA; Kaledin VI; Popova NA; Nikolin VP; Vasil'eva ED; Grigor'ev IA; Lushnikova EL; Nepomnyashchikh LM
    Bull Exp Biol Med; 2010 Dec; 150(1):75-8. PubMed ID: 21161057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclophosphamide-induced apoptosis of murine lymphosarcoma cells in vivo].
    Kaledin VI; Nikolin VP; Ageeva TA; Timofeeva OA; Filipenko ML; Ronichevskaia GM; Morozkova TS; Popova NA; Baĭmak TIu
    Vopr Onkol; 2000; 46(5):588-93. PubMed ID: 11202193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice.
    Schubert R; Erker L; Barlow C; Yakushiji H; Larson D; Russo A; Mitchell JB; Wynshaw-Boris A
    Hum Mol Genet; 2004 Aug; 13(16):1793-802. PubMed ID: 15213104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tempol, a stable free radical, is a novel murine radiation protector.
    Hahn SM; Tochner Z; Krishna CM; Glass J; Wilson L; Samuni A; Sprague M; Venzon D; Glatstein E; Mitchell JB
    Cancer Res; 1992 Apr; 52(7):1750-3. PubMed ID: 1551104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of catecholaminergic oxidative toxicity by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl and its recycling complex with polynitroxylated albumin, TEMPOL/PNA.
    Weinberg A; Nylander KD; Yan C; Ma L; Hsia CJ; Tyurin VA; Kagan VE; Schor NF
    Brain Res; 2004 Jun; 1012(1-2):13-21. PubMed ID: 15158156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain.
    Korolenko TA; Djanayeva SJ; Falameyeva OV; Wevers RA; Filjushina EE; Buzueva II; Kaledin VI; Sandula J; Nowicky J
    Drugs Exp Clin Res; 2000; 26(5-6):279-83. PubMed ID: 11345039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
    Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
    Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
    Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
    Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal model of drug-resistant tumor progression.
    Mironova N; Shklyaeva O; Andreeva E; Popova N; Kaledin V; Nikolin V; Vlassov V; Zenkova M
    Ann N Y Acad Sci; 2006 Dec; 1091():490-500. PubMed ID: 17341638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 2,3-dihydroxybenzoic acid and tempol in prevention of vancomycin-induced nephrotoxicity in rats.
    Naghibi B; Ghafghazi T; Hajhashemi V; Talebi A; Taheri D
    Toxicology; 2007 Apr; 232(3):192-9. PubMed ID: 17296255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nitroxide tempol has similar antioxidant effects as physiological levels of 17beta-oestradiol in reversing ovariectomy-induced oxidative stress in mice liver and kidney.
    Enli Y; Oztekin O; Pinarbasili RD
    Scand J Clin Lab Invest; 2009; 69(4):526-34. PubMed ID: 19343575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulatory effect of tempol on toxicity and antitumor activity of 6-mercaptopurine and on P450 cytochrome level.
    Konovalova NP; Diatchkovskaya RF; Volkova LM; Varfolomeev VN
    Neoplasma; 1996; 43(5):341-6. PubMed ID: 8996555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of TEMPOL-hydroxylamine during reaction between TEMPOL and hydroxyl radical: HPLC/ECD study.
    Kudo W; Yamato M; Yamada K; Kinoshita Y; Shiba T; Watanabe T; Utsumi H
    Free Radic Res; 2008 May; 42(5):505-12. PubMed ID: 18484414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of tempol for prevention of xerostomia following head and neck irradiation in a mouse model.
    Cotrim AP; Sowers AL; Lodde BM; Vitolo JM; Kingman A; Russo A; Mitchell JB; Baum BJ
    Clin Cancer Res; 2005 Oct; 11(20):7564-8. PubMed ID: 16243832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tempol, a membrane-permeable radical scavenger, on mesenteric blood flow and organ injury in a murine cecal ligation and puncture model of septic shock.
    Yuksel BC; Serdar SE; Tuncel A; Uzum N; Ataoglu O; Atan A; Hengirmen S; Iskit AB; Guc MO
    Eur Surg Res; 2009; 43(2):219-27. PubMed ID: 19556798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
    Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
    Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nitroxide antioxidant Tempol affects metal-induced cyto- and genotoxicity in human lymphocytes in vitro.
    Lewinska A; Wnuk M; Slota E; Bartosz G
    Mutat Res; 2008 Jan; 649(1-2):7-14. PubMed ID: 17950026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive treatment of murine neuroblastoma with 6-hydroxydopamine and Tempol.
    Purpura P; Westman L; Will P; Eidelman A; Kagan VE; Osipov AN; Schor NF
    Cancer Res; 1996 May; 56(10):2336-42. PubMed ID: 8625308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.